2013
Thompson CM, Proctor DM, Suh M , Haws LC, Kirman CR, Harris MA. 2013. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans. Crit Rev Toxicol 43(3):244-274; doi: 10.3109/10408444.2013.768596 . PMID: 23445218.
View Abstract
Topics: chromium , Exposure Assessment , mode of action
2012
Kirman CR, Hays SM, Aylward LL, Suh M , Harris MA, Thompson CM, Haws LC, Proctor DM. 2012. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium. Chem Biol Interact 200(1):45-64; doi: 10.1016/j.cbi.2012.08.016 . PMID: 22981460.
View Abstract
Topics: chromium , modeling , pharmacokinetics
Proctor DM, Suh M , Aylward LL, Kirman CR, Harris MA, Thompson CM, Gürleyük H, Gerads R, Haws LC, Hays SM. 2012. Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere 89(5):487-493; doi: 10.1016/j.chemosphere.2012.04.065 . PMID: 22682893.
View Abstract
Topics: chromium
Thompson CM, Hixon JG, Proctor DM, Haws LC, Suh M , Urban JD, Harris MA. 2012. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: An in silico comparison with mutagenic and nonmutagenic carcinogens across tissues. Regul Toxicol Pharmacol 64(1):68-76; doi: 10.1016/j.yrtph.2012.05.019 . PMID: 22705708.
View Abstract
Topics: chromium , genotoxicity
Alexander D, Weed D, Mink P, Mitchell M . 2012. A weight-of-evidence review of colorectal cancer in pesticide applicators: The agricultural health study and other epidemiologic studies. Int Arch Occup Environ Health 85(7):715–745; doi: 10.1007/s00420-011-0723-7 . PMID: 22159924.
View Abstract